Literature DB >> 32958716

The Class A Carbapenemases BKC-1 and GPC-1 Both Originate from the Bacterial Genus Shinella.

Nicolas Kieffer1,2, Stefan Ebmeyer1,2, D G Joakim Larsson3,2.   

Abstract

Comparative genomics identified the environmental bacterial genus Shinella as the most likely origin of the class A carbapenemases BKC-1 and GPC-1. Available sequences and PCR analyses of additional Shinella species revealed homologous β-lactamases showing up to 85.4% and 93.3% amino acid identity to both enzymes, respectively. The genes conferred resistance to β-lactams once expressed in Escherichia coli bla BKC-1 likely evolved from a putative ancestral Shinella gene with higher homology through duplication of a gene fragment.
Copyright © 2020 Kieffer et al.

Entities:  

Keywords:  Gram-negative bacteria; antibiotic resistance; antimicrobial resistance; carbapenemase; class A; environment; origin; β-lactamase

Mesh:

Substances:

Year:  2020        PMID: 32958716      PMCID: PMC7674036          DOI: 10.1128/AAC.01263-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


INTRODUCTION

The high potential of Gram-negative bacteria to acquire exogenous DNA through horizontal gene transfer has allowed clinically relevant bacteria to acquire resistance toward many antibiotics (1, 2). The acquisition of carbapenemase genes in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii represents one of the most important threats, compromising the use of the entire β-lactam family. Recently, two novel carbapenemase genes, blaBKC-1 and blaGPC-1, were characterized (3, 4). The genes code for weak class A carbapenemases sporadically identified in Klebsiella pneumoniae and P. aeruginosa isolates, respectively. The two enzymes, BKC-1 and GPC-1, share 77% amino acid identity, but their exact origins remain unknown. The aim of this study was to investigate the origin of both blaBKC-1 and blaGPC-1. All bacterial genomes and plasmids (n = 610,187, downloaded March 2020) available in GenBank were searched for the blaGPC-1 and blaBKC-1-like genes, using DIAMOND v0.9.24.125 at a 70% identity cutoff (5). The blaGPC-1/BKC-1-like genes were identified in 19 assemblies and plasmids. In addition to the presence of blaBKC-1 in the originally reported plasmid from K. pneumoniae, the most similar sequences were found in two Shinella zoogloeoides chromosomes (81.7% and 85.4% amino acid [aa] identity, but if the duplication of part of the gene sequence is considered, the identity is up to 90.2%; see Discussion). The blaGPC-1-like genes were found in 14 different Shinella spp. genomes (S. granuli, S. kummerowiae, S. curvata, Shinella spp.; 80.1 to 93.3% aa identity), and two genomes whose global average nucleotide identity (gANI) analysis showed they are likely to be related to Shinella species and may have been misnamed (Sinorhizobium sp. RAC02 [84.9% aa identity] and uncharacterized Rhizobiaceae bacterium UBA3138 [78.9% aa identity]). Analysis of the two genes’ genetic environments in K. pneumoniae and P. aeruginosa showed the previously demonstrated association with both insertion sequences and plasmid-specific genes (Fig. 1). On the contrary, no insertion sequence or other genes indicating mobility could be associated with the homologues of blaGPC-1/BKC-1 found in Shinella spp. The blaGPC-1 and the blaBKC-1 homologs found in different Shinella spp. were located on the same chromosomal locus as indicated by strong synteny (Fig. 1). Sequence dissimilarities of 7% to ≥20% across this locus between species indicate a long-standing association with the Shinella genus (Fig. 1). Moreover, analysis of the sequences immediately up- and downstream of blaGPC-1 and blaBKC-1 showed high homologies with the corresponding loci in Shinella. The upstream and downstream regions of the blaGPC-1 gene shared 85% (44/52) and 86% (48/56) nucleotide identity with S. granuli DD12, while for the blaBKC-1 gene, the corresponding identities to S. zoogloeoides DSM287 were 80% (12/15) and 87% (87/100), respectively.
FIG 1

Comparative analysis of GPC-1/BKC-1-like loci. Striped arrows denote GPC-1/BKC-1-like genes, dark spotted arrows symbolize transposition associated genes such as IS, and light spotted arrows denote other genes associated with mobility. Light gray areas between graphs symbolize sequence alignment. Nucleotide alignment identities between GPC-1/BKC-1-like loci top to bottom: P. aeruginosa to S. spp JR1-6: 89% to 90%; S. spp JR1-6 to S. granuli, 70% to 93%; S. granuli to S. kummerowiae, 84% to 88%; S. kummerowiae to S. zoogloeoides, 84% to 86%; S. zoogloeoides to K. pneumoniae, 87%. Protein name abbreviations: Gdpd, putative glycerophosphoryl diester phosphodiesterase; Pd, phosphodiesterase; Nsps, norspermidine sensor; RNAtr, putative RNA-binding transcriptional regulator; Tr, ArsR family transcriptional regulator; Gly, glyoxalase/bleomycin resistance protein/dihydroxybiphenyl dioxygenase; Tp, l,d-transpeptidase catalytic domain protein; RecO, DNA repair protein RecO; Padp, phenylactetic acid degradation protein; DUF389, DUF389-containing protein; Pmp, predicted membrane protein; Era, GTPase Era; Phd, putative HD superfamily hydrolase. Nucleotide sequence accessions top to bottom: MN628598, SHMI01000003.1, SLVX01000002.1, WUMK01000006.1, WUML01000002.1, and KP689347.

Comparative analysis of GPC-1/BKC-1-like loci. Striped arrows denote GPC-1/BKC-1-like genes, dark spotted arrows symbolize transposition associated genes such as IS, and light spotted arrows denote other genes associated with mobility. Light gray areas between graphs symbolize sequence alignment. Nucleotide alignment identities between GPC-1/BKC-1-like loci top to bottom: P. aeruginosa to S. spp JR1-6: 89% to 90%; S. spp JR1-6 to S. granuli, 70% to 93%; S. granuli to S. kummerowiae, 84% to 88%; S. kummerowiae to S. zoogloeoides, 84% to 86%; S. zoogloeoides to K. pneumoniae, 87%. Protein name abbreviations: Gdpd, putative glycerophosphoryl diester phosphodiesterase; Pd, phosphodiesterase; Nsps, norspermidine sensor; RNAtr, putative RNA-binding transcriptional regulator; Tr, ArsR family transcriptional regulator; Gly, glyoxalase/bleomycin resistance protein/dihydroxybiphenyl dioxygenase; Tp, l,d-transpeptidase catalytic domain protein; RecO, DNA repair protein RecO; Padp, phenylactetic acid degradation protein; DUF389, DUF389-containing protein; Pmp, predicted membrane protein; Era, GTPase Era; Phd, putative HD superfamily hydrolase. Nucleotide sequence accessions top to bottom: MN628598, SHMI01000003.1, SLVX01000002.1, WUMK01000006.1, WUML01000002.1, and KP689347. The GC content of the blaBKC/GPC-like genes from all Shinella isolates and their mobile counterparts ranged from 65.3% to 69.7%. This overlaps with that of the larger (±10,000 bp) genetic contexts in Shinella (63.8% to 66.6%) but not with that of clinical species carrying blaBKC/GPC genes (59.3% to 60.5%). Altogether, this indicates that the two resistance genes share an ancestor gene that have evolved separately into a more blaBKC-1-like gene in S. zoogloeoides and a more blaGPC-1-like gene in, e.g., S. granuli. It is therefore highly plausible that that blaGPC-1 and blaBKC-1 were mobilized from different Shinella spp. To evaluate the phenotype provided by the blaBKC/GPC-like gene and to find other variants and potential closer homologs, four different Shinella species were recovered from the public bacterial collection bank of the Culture Collection of the University of Gothenburg (CCUG), being S. granuli 56487, S. kummerowiae 56777, S. zoogloeoides 35204, and S. fusca 55808 (6–8). PCR experiments using degenerate primers were performed, and amplified β-lactamase genes (named blaGPG, blaGPK, blaGPZ, and blaGPF, respectively) were cloned into E. coli TOP10 using the pCR2-TOPO cloning kit (Thermo Fisher) and tested for the resistance phenotype using broth microdilution. A CarbaNP test (9) confirmed the ability of the GPC/BKC-like expressing clones to hydrolyze imipenem. All clones displayed a resistance profile against β-lactams, including amino- and ureidopenicillins, first- and second-generation cephalosporins and a low level of resistance against third- and fourth-generation cephalosporins, monobactam, and carbapenems. All clones remained susceptible to the cephamycin cefoxitin. In addition, the use of clavulanic acid or avibactam restored a complete susceptibility against amoxicillin or ceftazidime, respectively, a characteristic shared by class A β-lactamases (Table 1). This phenotype is in accordance with those reported for BKC-1 and GPC-1 (3, 4). Protein alignments using SeaView Software (Prabi, Doua, France) showed that GPC-1 was most closely related to the GPC-like proteins from Shinella sp. strian DD12 (93.3%) and S. granuli (92.6%), whereas BKC-1 shared the highest amino acid identity with S. zoogloeoides (85.4%) (see Fig. S1 in the supplemental material). All variants possessed the typical conserved serine/threonine kinase motifs and the motif involved in the Ω-loop formation of class A β-lactamases (10) (Fig. 2). Deeper alignment analysis showed that BKC-1 displayed a duplication of 16 amino acids, being the repetition of the protein segment from Ala12 to Ser27. Therefore, a putative ancestral protein was designed in silico and named BKC-b (Fig. 2). Aligning the BKC-b sequence with GPZ increased the amino acid identity up to 90.2% compared to 85.4% without the duplication (Fig. S1). Production of BKC-b in E. coli TOP10 showed a weaker resistance profile while having an increased activity against cefoxitin. The use of the I-TASSER (11) in silico tool predicted the tridimensional structures of both BKC-b and BKC-1 and showed that the duplication of the protein segment in BKC-1 modified the ligand binding site of the enzyme and probably led to the increased spectrum of activity observed in BKC-1 compared to that in BKC-b but the loss of its activity against cephamycins.
TABLE 1

MICs of the clones expressing the different BKC and GPC variants

Clone or strainMIC (μg/ml)a
AMXAMCPIPCEFFOXCXMCTXCAZCZAFEPATMIPMMEMERT
E. coli TOP104424440.1250.250.25<0.1250.1250.125<0.125<0.125
pGPC-1>256664>25662563210.252410.25<0.125
pBKC-1>256432>2566>2563240.251210.1250.125
pBKC-b326432646420.50.250.1250.50.25<0.125<0.125
pGPG>256481683210.50.250.2510.5<0.125<0.125
pGPK>2568>256>2568>256320.50.250.7581<0.125<0.125
pGPZ>2564>256>2568>2563210.250.251620.250.25
pGPF>2566128>256812840.50.250.521<0.125<0.125

AMX, amoxicillin; AMC, amoxicillin-clavulanic acid; PIP, piperacillin; CEF, cephalothin; FOX, cefoxitin; CXM, cefuroxime; CTX, cefotaxime; CAZ, ceftazidime; CZA, ceftazidime-avibactam; FEP, cefepime; ATM, aztreonam; IPM, imipenem; MEM, meropenem; ERT, ertapenem.

FIG 2

Amino acid sequence comparison between the different BKC/GPC-like enzymes. A dash represents an amino acid that is common among all variants, a slash represents a gap. The underlined sequence represents the duplication of the peptide Ala12 to Ser27 in BKC-1. Bolded sequences implicated the conserved motifs present in class A β-lactamases: 70STFK, 130SDN, 234KTG involved in the catalytic activity and 166EPxLN, involved in the Ω-loop (ABL numbering).

MICs of the clones expressing the different BKC and GPC variants AMX, amoxicillin; AMC, amoxicillin-clavulanic acid; PIP, piperacillin; CEF, cephalothin; FOX, cefoxitin; CXM, cefuroxime; CTX, cefotaxime; CAZ, ceftazidime; CZA, ceftazidime-avibactam; FEP, cefepime; ATM, aztreonam; IPM, imipenem; MEM, meropenem; ERT, ertapenem. Amino acid sequence comparison between the different BKC/GPC-like enzymes. A dash represents an amino acid that is common among all variants, a slash represents a gap. The underlined sequence represents the duplication of the peptide Ala12 to Ser27 in BKC-1. Bolded sequences implicated the conserved motifs present in class A β-lactamases: 70STFK, 130SDN, 234KTG involved in the catalytic activity and 166EPxLN, involved in the Ω-loop (ABL numbering). Here, we provide evidence that the genes blaGPC-1 and blaBKC-1 were most likely mobilized from members of bacterial genus Shinella into clinical species. This conclusion is based on the presence of a conserved locus containing a blaGPC/BKC-like gene in all investigated Shinella species, the lack of associated mobile genetic elements, and high amino acid and nucleotide identities to the clinical counterparts, but not so high that we could assign with confidence the exact origin species. However, it is highly plausible that the origins of blaGPC-1 and blaBKC-1 are Shinella species closely related to S. granuli and S. zoogloeoides, respectively. The resistance phenotype provided by the blaGPC/BKC-like genes is in line with mobilization and transfer driven by antibiotic exposure. The Shinella genus includes mesophilic, aerobic Gram-negative species mainly recovered from environmental samples. For instance, the studied S. granuli and S. zoogloeoides isolates were recovered from sludge in China, while the S. kummerowiae and S. fusca isolates were recovered from root nodules and domestic compost in Korea and Portugal, respectively (6–8). The presence of a natural and functional β-lactamase gene in this genus could be explained by the presence of β-lactam-producing microorganisms sharing the same niche (12). Additionally, we show that the BKC-1 protein presented a duplication of its Ala12-Ser27 segment, likely from a putative ancestral protein BKC-b. Hence, the blaBKC-1 gene may have evolved from blaBKC-b, likely under a selective pressure from β-lactams, eventually resulting in a more efficient enzyme. This mutation led, on the other hand, to the reduction of its activity against cefoxitin. Emergence of new resistance genes, especially genes providing resistance to antibiotics of last resort, such as carbapenems, represents a major clinical threat. After initial emergence, they are likely to remain undetected and spread silently in the human microbiota for some time. When detected, they are often already widespread (13). Understanding the origin and mobilization history of as many and diverse clinically important resistance genes as possible could enable us to manage risks for future emergence events in a better way. The data presented here provides one additional piece in this large puzzle.

Data availability.

The nucleotide sequence of the carbapenemases genes blaGPG, blaGPK, blaGPZ, blaGPF, and blaBKC-b were submitted to GenBank with the following accession numbers, respectively: MT661611, MT661612, MT661613, MT661614, and MT661610.
  12 in total

1.  Fast and sensitive protein alignment using DIAMOND.

Authors:  Benjamin Buchfink; Chao Xie; Daniel H Huson
Journal:  Nat Methods       Date:  2014-11-17       Impact factor: 28.547

2.  The I-TASSER Suite: protein structure and function prediction.

Authors:  Jianyi Yang; Renxiang Yan; Ambrish Roy; Dong Xu; Jonathan Poisson; Yang Zhang
Journal:  Nat Methods       Date:  2015-01       Impact factor: 28.547

3.  Shinella kummerowiae sp. nov., a symbiotic bacterium isolated from root nodules of the herbal legume Kummerowia stipulacea.

Authors:  Dong Xu Lin; En Tao Wang; Hui Tang; Tian Xu Han; Yu Rong He; Su Hua Guan; Wen Xin Chen
Journal:  Int J Syst Evol Microbiol       Date:  2008-06       Impact factor: 2.747

4.  Shinella fusca sp. nov., isolated from domestic waste compost.

Authors:  Ivone Vaz-Moreira; Cátia Faria; Ana R Lopes; Liselott A Svensson; Edward R B Moore; Olga C Nunes; Célia M Manaia
Journal:  Int J Syst Evol Microbiol       Date:  2009-07-31       Impact factor: 2.747

5.  Characterization of BKC-1 class A carbapenemase from Klebsiella pneumoniae clinical isolates in Brazil.

Authors:  Adriana Giannini Nicoletti; Marcelo F M Marcondes; Willames M B S Martins; Luiz G P Almeida; Marisa F Nicolás; Ana T R Vasconcelos; Vitor Oliveira; Ana Cristina Gales
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

6.  GPC-1, a novel class A carbapenemase detected in a clinical Pseudomonas aeruginosa isolate.

Authors:  Jennifer Schauer; Sören G Gatermann; Daniel Hoffmann; Lars Hupfeld; Niels Pfennigwerth
Journal:  J Antimicrob Chemother       Date:  2020-04-01       Impact factor: 5.790

Review 7.  Plasmid-mediated resistance is going wild.

Authors:  Monika Dolejska; Costas C Papagiannitsis
Journal:  Plasmid       Date:  2018-09-21       Impact factor: 3.466

8.  Rapid detection of carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Laurent Poirel; Laurent Dortet
Journal:  Emerg Infect Dis       Date:  2012-09       Impact factor: 6.883

Review 9.  Environmental factors influencing the development and spread of antibiotic resistance.

Authors:  Johan Bengtsson-Palme; Erik Kristiansson; D G Joakim Larsson
Journal:  FEMS Microbiol Rev       Date:  2018-01-01       Impact factor: 16.408

10.  Variations within class-A β-lactamase physiochemical properties reflect evolutionary and environmental patterns, but not antibiotic specificity.

Authors:  Deeptak Verma; Donald J Jacobs; Dennis R Livesay
Journal:  PLoS Comput Biol       Date:  2013-07-18       Impact factor: 4.475

View more
  4 in total

1.  BKC-2, a New BKC Variant Detected in MCR-9.1-Producing Enterobacter hormaechei subsp. xiangfangensis.

Authors:  Willames M B S Martins; Evelin R Martins; Letícia K de Andrade; Refath Farzana; Timothy R Walsh; Mark A Toleman; Mara C L Nogueira; Ana C Gales
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  Co-production of Classes A and B Carbapenemases BKC-1 and VIM-2 in a Clinical Pseudomonas Putida Group Isolate from Brazil.

Authors:  Amanda Yaeko Yamada; Andreia Rodrigues de Souza; Marisa de Jesus de Castro Lima; Alex Domingos Reis; Karoline Rodrigues Campos; Amanda Maria de Jesus Bertani; Leonardo Jose Tadeu de Araujo; Claudio Tavares Sacchi; Monique Ribeiro Tiba-Casas; Carlos Henrique Camargo
Journal:  Curr Microbiol       Date:  2022-07-14       Impact factor: 2.343

3.  A framework for identifying the recent origins of mobile antibiotic resistance genes.

Authors:  Stefan Ebmeyer; Erik Kristiansson; D G Joakim Larsson
Journal:  Commun Biol       Date:  2021-01-04

4.  The Carbapenemase BKC-1 from Klebsiella pneumoniae Is Adapted for Translocation by Both the Tat and Sec Translocons.

Authors:  Manasa Bharathwaj; Chaille T Webb; Grishma Vadlamani; Christopher J Stubenrauch; Tracy Palmer; Trevor Lithgow
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.